152 results on '"Kamiunten, Ayako"'
Search Results
2. Whole-genome landscape of adult T-cell leukemia/lymphoma
3. Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers
4. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
5. Monocyte-derived fibrocytes elimination had little contribution on liver fibrosis
6. TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia
7. Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia
8. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan
9. Table S2 from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
10. Supplementary Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
11. Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
12. Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
13. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
14. Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator
15. Preclinical Translational Research Suggests a Clinical Trial Strategy for a Novel MALT1 Inhibitor ONO-7018/CTX-177 Against Malignant Lymphomas
16. Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma
17. The effect of CARD11 mutation and HBZ expression accelerated lymphoproliferative diseases and formed the pathological basis for adult T-cell leukemia/lymphoma
18. Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
19. Clinical Outcomes of Tucidinostat Therapy for Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma (ATL) in Clinical Practice
20. TYK2 Is Essential for IFNα-Induced Resolution of MPN Features in a Murine Jak2V617F PMF Model
21. Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan
22. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphoma
23. Whole-Genome Analysis of Adult T-Cell Leukemia/Lymphoma
24. Preclinical Evaluation of a Novel MALT1 Inhibitor CTX-177 for Relapse/Refractory Lymphomas
25. CARD11 Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ
26. Dissecting Multicellular Ecosystems of HTLV-1 Infection and ATL By Multi-Omics Single Cell Analysis
27. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
28. Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms
29. TP53 and PTEN Mutations Were Shared in Concurrent Germ Cell Tumor and Acute Megakaryoblastic Leukemia
30. Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
31. Depletion of Neoplastic CD11b Positive Cells in Jak2V617F Mutant Mice Reduced Fibrocytes in Bone Marrow and Improved Myelofibrosis
32. The Role of Calreticulin in Normal Hematopoiesis and Neoplastic Hematopoiesis of Myeloproliferative Neoplasms
33. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphoma.
34. Haploinsufficiency of CALR Confers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the Calr Mutation
35. TET2 Mutation Associated with Organ Infiltrations in ATLL
36. Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia
37. Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice
38. Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
39. TET2 mutation in diffuse large B-cell lymphoma
40. Physiological Expression of Calr Mutant Increases Cell Growth and Cytokine Independency in Human Cell Lines Expressing Mpl, and Develops Essential Thrombocythemia in Mice
41. Mogamulizumab for ATLL in Clinical Practice
42. Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms
43. TET2 Mutation in Adult T-Cell Leukemia/Lymphoma
44. Nasopharyngeal Carcinoma with Bone Marrow Metastasis: Positive Response to Weekly Paclitaxel Chemotherapy
45. Therapies Targeting the MAPK Pathway Improve Bone Marrow (BM) Fibrosis Induced By JAK2V617F
46. CARD11Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ
47. Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan.
48. TET2Mutation Associated with Organ Infiltrations in ATLL
49. Haploinsufficiency of CALRConfers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the CalrMutation
50. [Myeloproliferative neoplasms: revisions in the 2016 WHO criteria].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.